Company Website: http://www.johnsonandweaver.com
SAN DIEGO -- (Business Wire)

Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by ConforMIS, Inc. (NASDAQ:CFMS) and certain of its officers and directors. ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's unique anatomy.

Specifically, Johnson & Weaver’s investigation seeks to determine whether certain statements regarding ConforMIS’s business and prospects were false and misleading when made.

On July 1, 2015, ConforMIS stock opened for trading at $18.00, the same day that the Company sold 9.0 million shares of stock in its initial public stock offering (“IPO”). However, in early morning trading on August 31, 2015, just two months after its IPO, ConforMIS common stock has dropped below $16.00 per share. ConforMIS shares have traded as high as $26.93 just several weeks ago.

ConforMIS’s stock price decline resulted from a Company issued press release on August 31, 2015 announcing that it had initiated a voluntary recall of specific serial numbers of patient-specific instrumentation for its iUni, iDuo, iTotal CR and iTotal PS knee replacement product systems. ConforMIS instigated the recall in response to three recent complaints of moisture on the patient-specific instrumentation.

If you have information that could assist in this investigation, or if you are a ConforMIS shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150831005842/en/

Contacts:

Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

Source: Johnson & Weaver, LLP